Skip to main content
Skip to main content
CCTSW logo

Cactus Acquisition Corp. 1 Limited (CCTSW) Stock Analysis

$0.03 +$0.0072 (+31.58%)
Vol: 16.2K| 52-wk range: $0.0238 – $0.03
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cactus Acquisition Corp. 1 Limited (CCTSW) trades at $0.03. Cactus Acquisition Corp. 1 Limited is a shell company focused on merging with a technology-based healthcare business. Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026
Cactus Acquisition Corp. 1 Limited is a shell company focused on merging with a technology-based healthcare business. The company was incorporated in 2021 and is based in Cranbury, New Jersey.

Analyst Coverage for CCTSW: CCTSW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CCTSW against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the CCTSW film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Not yet rated

Not enough scored data yet to form a council read on CCTSW.

How is this calculated? →
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Cactus Acquisition Corp. 1 Limited (CCTSW) Financial Services Profile

CEOGary Challinor
HeadquartersCranbury, US

Cactus Acquisition Corp. 1 Limited is a special purpose acquisition company (SPAC) targeting a merger within the technology-based healthcare sector. Incorporated in 2021, the company seeks to identify and acquire a high-growth business, offering investors exposure to potential upside through a streamlined acquisition process.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CCTSW?

As of Mar 17, 2026 — figures reflect the data available on that date.

Cactus Acquisition Corp. 1 Limited presents a speculative investment opportunity centered on its ability to successfully identify and merge with a promising technology-based healthcare company. The company's valuation is currently tied to its cash holdings, with potential upside contingent on the quality and growth prospects of its eventual acquisition target. A successful merger could lead to significant share price appreciation, driven by investor enthusiasm for the combined entity's prospects. However, the investment is subject to substantial risks, including the possibility that Cactus Acquisition Corp. 1 Limited may be unable to find a suitable target within the allotted timeframe, leading to the liquidation of the SPAC and a return of capital to shareholders. Furthermore, even if a merger is completed, the success of the combined entity is not guaranteed and will depend on factors such as market conditions, competitive pressures, and the execution of the management team's strategy. The company's P/E ratio is currently -9935.80, reflecting its current lack of profitability.

Based on FMP financials and quantitative analysis

CCTSW Key Highlights

Cactus Acquisition Corp. 1 Limited is a special purpose acquisition company (SPAC) focused on the technology-based healthcare sector.

  • The company was incorporated in 2021 and is based in Cranbury, New Jersey.
  • Cactus Acquisition Corp. 1 Limited is seeking a merger, amalgamation, share exchange, or other business combination.
  • The company's success depends on identifying and acquiring a high-quality target company.
  • CCTSW has a Beta of 0.01, indicating low volatility relative to the market.

Who Are CCTSW's Competitors?

CCTSW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NIHL New Infinity Holdings, Ltd. $0.10 +0.00% $10.8M 62
LRGR Luminar Media Group, Inc. $0.50 +47.06% $22.4M 68
CLAYU Chavant Capital Acquisition Corp. $10.97 +18.34% $27.5M 62
CLAY Chavant Capital Acquisition Corp. $10.66 +6.39% $29.6M 62
INACU Indigo Acquisition Corp. $12.08 +16.94% $34.9M 60
HHGC HHG Capital Corporation $11.12 +0.09% $56.2M 63
MAAQ Mana Capital Acquisition Corp. $5.99 -24.18% $57.0M 61
RCLFU Rosecliff Acquisition Corp I $11.33 +11.74% $77.2M 62

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CCTSW's Key Strengths?

Experienced management team with a track record in acquisitions.

  • Focus on the high-growth technology-based healthcare sector.
  • Access to capital through the public markets.
  • Flexibility to pursue a wide range of business combinations.

What Are CCTSW's Weaknesses?

Dependence on identifying and acquiring a suitable target company.

  • Competition from other SPACs seeking acquisition targets.
  • Uncertainty regarding the future performance of the acquired company.
  • Potential for dilution of shareholder value through future equity offerings.

What Could Drive CCTSW Stock Higher?

Announcement of a definitive agreement to merge with a target company.

  • Progress in negotiations with potential target companies.
  • Positive developments in the technology-based healthcare sector.

What Are the Key Risks for CCTSW?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Failure to identify and acquire a suitable target company within the allotted timeframe.
  • Economic downturn or market volatility impacting the valuation of potential target companies.
  • Changes in regulatory requirements affecting the healthcare or technology industries.
  • Competition from other SPACs seeking acquisition targets.
  • Uncertainty regarding the future performance of the acquired company.

What Are the Growth Opportunities for CCTSW?

  • Successful Target Acquisition: Cactus Acquisition Corp. 1 Limited's primary growth opportunity lies in identifying and acquiring a high-growth technology-based healthcare company. The timeline for this growth opportunity is dependent on the company's ability to complete a merger within the next 12-24 months. A successful acquisition could drive substantial revenue growth and market share gains.
  • Technological Innovation: By focusing on technology-based healthcare businesses, Cactus Acquisition Corp. 1 Limited can capitalize on the growing demand for innovative healthcare solutions. The market for telehealth, remote patient monitoring, and digital therapeutics is expanding rapidly, driven by factors such as aging populations, rising healthcare costs, and increasing adoption of digital technologies. The timeline for this growth opportunity is ongoing, as technological advancements continue to reshape the healthcare landscape. A successful merger with a company at the forefront of these innovations could position the combined entity for long-term success.
  • Operational Synergies: Following a successful merger, Cactus Acquisition Corp. 1 Limited can pursue operational synergies to improve efficiency and profitability. This may involve streamlining operations, consolidating resources, and leveraging the combined entity's scale to negotiate better terms with suppliers and vendors. The timeline for this growth opportunity is typically within the first 12-18 months after the merger is completed. Realizing these synergies can enhance the combined entity's financial performance and create value for shareholders.
  • Market Expansion: A successful merger could provide Cactus Acquisition Corp. 1 Limited with the opportunity to expand into new geographic markets or customer segments. This may involve leveraging the target company's existing distribution channels or developing new partnerships to reach a wider audience. The timeline for this growth opportunity is dependent on the specific characteristics of the target company and the market opportunities available. Expanding into new markets can drive revenue growth and diversify the combined entity's revenue streams.
  • Strategic Partnerships: Cactus Acquisition Corp. 1 Limited can pursue strategic partnerships with other companies in the healthcare or technology sectors to accelerate growth and expand its capabilities. This may involve collaborating on research and development projects, co-marketing products and services, or forming joint ventures to pursue specific market opportunities. The timeline for this growth opportunity is ongoing, as new partnership opportunities may arise at any time. Strategic partnerships can provide access to new technologies, markets, and expertise, enhancing the combined entity's competitive position.

What Are CCTSW's Competitive Advantages?

  • Management team's experience in identifying and executing successful acquisitions.
  • Focus on the high-growth technology-based healthcare sector.
  • Access to capital through the public markets.
  • Ability to provide a streamlined path to going public for private companies.

What Does CCTSW Do?

Cactus Acquisition Corp. 1 Limited, incorporated in 2021 and based in Cranbury, New Jersey, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more private entities. Cactus Acquisition Corp. 1 Limited is specifically focused on pursuing opportunities within the technology-based healthcare sector, aiming to leverage technological advancements to improve healthcare delivery and outcomes. The company's strategy involves conducting thorough due diligence on potential target companies, assessing their financial performance, growth prospects, and competitive positioning. Cactus Acquisition Corp. 1 Limited seeks to identify businesses with strong management teams, innovative technologies, and significant market opportunities. Upon identifying a suitable target, the company negotiates the terms of the business combination and works to secure the necessary regulatory approvals. As a SPAC, Cactus Acquisition Corp. 1 Limited offers investors the opportunity to participate in a private equity-style investment through a publicly traded vehicle. The company's success depends on its ability to identify and acquire a high-quality target company that can deliver long-term value to shareholders. The focus on technology-based healthcare reflects the growing importance of technology in transforming the healthcare industry and the potential for significant returns in this sector.

What Products and Services Does CCTSW Offer?

  • Cactus Acquisition Corp. 1 Limited is a special purpose acquisition company (SPAC).
  • The company's primary goal is to identify and merge with a private company.
  • They focus on businesses within the technology-based healthcare sector.
  • Cactus Acquisition Corp. 1 Limited seeks to provide investors with access to private equity-style investments.
  • The company conducts due diligence on potential target companies.
  • They negotiate the terms of a business combination with the chosen target.
  • Cactus Acquisition Corp. 1 Limited works to secure regulatory approvals for the merger.

How Does CCTSW Make Money?

  • Cactus Acquisition Corp. 1 Limited raises capital through an initial public offering (IPO).
  • The company uses the funds raised to identify and acquire a target company.
  • The business model relies on the expertise of the management team to find a suitable acquisition target.
  • Value creation occurs through the successful integration and growth of the acquired company.

What Industry Does CCTSW Operate In?

Cactus Acquisition Corp. 1 Limited operates within the SPAC market, a segment of the financial services industry characterized by companies formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing operating company. The SPAC market has experienced periods of rapid growth and increased scrutiny, with investors seeking opportunities to participate in private equity-style investments through publicly traded vehicles. The success of SPACs depends on their ability to identify and acquire attractive target companies, navigate regulatory hurdles, and deliver value to shareholders. The competitive landscape includes numerous other SPACs, each vying for promising acquisition targets.

Who Are CCTSW's Key Customers?

  • Institutional investors seeking exposure to the technology-based healthcare sector.
  • Retail investors interested in participating in private equity-style investments.
  • Target companies looking to go public through a merger with a SPAC.
AI Confidence: 71% Updated: Mar 17, 2026

Company Profile

Cactus Acquisition Corp. 1 Limited operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Cranbury, US. The company is led by CEO Gary Challinor.

F-Score 2/9

Financial Health

Cactus Acquisition Corp. 1 Limited's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

CCTSW Financials

Bull Case vs Bear Case

Bull Case

  • Experienced management team with a track record in acquisitions.
  • Focus on the high-growth technology-based healthcare sector.
  • Access to capital through the public markets.
  • Flexibility to pursue a wide range of business combinations.

Bear Case

  • Dependence on identifying and acquiring a suitable target company.
  • Competition from other SPACs seeking acquisition targets.
  • Uncertainty regarding the future performance of the acquired company.
  • Potential for dilution of shareholder value through future equity offerings.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

CCTSW Latest News

No recent news available for CCTSW.

CCTSW Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CCTSW.

Price Targets

Wall Street price target analysis for CCTSW.

CCTSW MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates CCTSW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Gary Challinor

CEO

Gary Challinor serves as the Chief Executive Officer of Cactus Acquisition Corp. 1 Limited. His career spans various leadership roles within the financial services and investment sectors. Challinor has a background in identifying and evaluating investment opportunities, structuring transactions, and managing portfolio companies. He brings experience in the healthcare and technology industries, which aligns with Cactus Acquisition Corp. 1 Limited's focus. His expertise includes financial analysis, due diligence, and strategic planning. Challinor's experience is expected to guide the company in its search for a suitable merger target.

Track Record: Gary Challinor's track record includes experience in sourcing and executing investment transactions. While specific achievements directly attributable to his leadership at Cactus Acquisition Corp. 1 Limited are pending the completion of a merger, his prior roles suggest a capability to navigate complex financial transactions. His leadership is focused on identifying a target company that will deliver long-term value to shareholders. His success will be measured by the performance of the acquired company.

Common Questions About CCTSW (Financial Services)

What does Cactus Acquisition Corp. 1 Limited do?

Cactus Acquisition Corp. 1 Limited is a special purpose acquisition company (SPAC) formed to identify and merge with a private company, primarily in the technology-based healthcare sector. The company raises capital through an initial public offering (IPO) and then seeks a suitable acquisition target.

What are the main risks for CCTSW?

The primary risk for Cactus Acquisition Corp. 1 Limited is the failure to identify and acquire a suitable target company within the allotted timeframe, which could lead to the liquidation of the SPAC and a return of capital to shareholders.

What are the key factors to evaluate for CCTSW?

Evaluate CCTSW on fundamentals, analyst consensus, and risk factors. Cactus Acquisition Corp. 1 Limited presents a speculative investment opportunity centered on its ability to successfully identify and merge with a promising technology-based healthcare company. Not financial advice.

How frequently does CCTSW data refresh on this page?

CCTSW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven CCTSW's recent stock price performance?

Cactus Acquisition Corp. 1 Limited (CCTSW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team with a track record in acquisitions. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CCTSW overvalued or undervalued right now?

Cactus Acquisition Corp. 1 Limited (CCTSW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research CCTSW before investing?

Before investing in Cactus Acquisition Corp. 1 Limited (CCTSW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CCTSW to a portfolio?

Key strength of Cactus Acquisition Corp. 1 Limited (CCTSW): Experienced management team with a track record in acquisitions. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • Investment in SPACs involves significant risks and uncertainties.
Data Sources

Popular Stocks

More Stocks We Cover